Skip to main content
Log in

Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms

  • Letter to the editors
  • Published:
Psychopharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Canadian Network for Mood and Anxiety Treatments (CANMAT) (1999) Guidelines for the diagnosis and pharmacological treatment of depression. Cameron McCleery Productions Ltd, Toronto, Canada

    Google Scholar 

  • Chehil S, Devarajan S, Dursun SM (2000) Pharmacological strategies for refractory depression. Can Fam Phys (in press)

    Google Scholar 

  • Cowen PJ (1998) Pharmacological management of treatment resistant depression. Adv Psychiatr Treat 4:320–327

    Article  Google Scholar 

  • Devarajan S, Dursun SM (2000) Citalopram plus reboxetine in treatment-resistant depression. Can J Psychiatry 45:489–490

    CAS  PubMed  Google Scholar 

  • Souery D, Amsterdam J, deMontigny C, Lecrubien Y, Montogemery S, Lipp O et al. (1999) Treatment resistant depression: methological overview and operational criteria. Eur Neuropsychiatr 9:83–91

    Article  CAS  Google Scholar 

  • O'Reardon JP, Amsterdam JD (1998) Treatment-resistant depression: progress and limitations. Psychiatr Ann 28:633–640

    Google Scholar 

  • Whale R, Quested DJ, Laver D, Harrison PJ, Cowen PJ (2000) Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine. Psychopharmacology 150:120–122

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S.M. Dursun.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dursun, S., Devarajan, S. Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms. Psychopharmacology 153, 497–498 (2001). https://doi.org/10.1007/s002130000579

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002130000579

Navigation